title: Natural gum as mucoadhesive controlled release carriers: evaluation of cefpodoxime proxetil by D-optimal design technique.
abstract: The present study deals with the development of mucoadhesive controlled release tablets of Cefpodoxime Proxetil to increase the gastric residence time and thus prolong drug release, reduce dosing frequency and improve oral bioavailability. Tablets were prepared using sodium alginate and karaya gum, a natural polymer, with a synthetic polymer hydroxypropylmethylcellulose (K100LV) and Karaya gum with HPMC K100LV in various ratios to optimize the drug release profile using D-Optimal technique. Pre- and post-compression parameters of tablets prepared with various formulations (S1-S9, C1-C9) were evaluated. The FTIR and DSC studies revealed that no physiochemical interaction between excipients and drug. The formulation S7 showed prolonged drug release, and the mechanism of drug release from the optimized formulation was confirmed using the Korsmeyer-Peppas model to be non-Fickian release transport and n value was found 0.605 indicating both diffusion and erosion mechanism from these natural gums. The optimized formulation showed mucoadhesive strength >35 g. An in vivo study was performed on rabbits using an X-ray imaging technique. The radiological evidence suggests that the tablets adheres (more than 10 hours) to a rabbit's stomach. No significant changes were found in the physical appearance, drug content, mucoadhesive study and in vitro dissolution pattern after storage at 40 °C/75% relative humidity for 3 months.
authors.affiliation: Department of Pharmaceutics, R.C. Patel Institute of Pharmaceutical Education and Research , Shirpur (M.S), Maharashtra , India and.
authors.forename: Satish H
authors.initials: SH
authors.lastname: Patil
authors.forename: Gokul S
authors.initials: GS
authors.lastname: Talele
mesh_terms: D000269:Adhesives / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D015296:Ceftizoxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism*; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism*; D007618:Karaya Gum / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism*; D011355:Prodrugs / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism; D011817:Rabbits; D013552:Swine; D000097627:Cefpodoxime Proxetil
chemical_list: D000269:Adhesives; D015296:Ceftizoxime; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D007618:Karaya Gum; D011355:Prodrugs; D000097627:Cefpodoxime Proxetil